InvestorsHub Logo
Followers 34
Posts 1982
Boards Moderated 0
Alias Born 01/25/2010

Re: None

Monday, 06/29/2015 8:41:45 AM

Monday, June 29, 2015 8:41:45 AM

Post# of 17485
FDA/Pharma Watch: ILNS
Exchange: OTCQB
Price: .29
Outstanding Shares (as of 5/11/15): 3,370,648
Market Cap: $977.5K (as of 6/29 pre-market)
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10691614

Significant Events
~Settled with Pfizer where Pfizer agreed to pay ILNS $1.2M at end of December 2014
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10394167

Pipeline
~Most advanced candidate: OX1 aka VP 20629 aka SHP622
~Clinical Study with Shire Plc (Nasdaq: SHPG) for Friedreich's Ataxia: rare inherited disease that causes nervous system damage and problems with mobility (obtained when ViroPharma Inc merged with Shire Plc)
~Shire's Phase 1 trial data due in July 2015, OX1 was safe after ILNS Phase 1b tests in 2010
https://www.clinicaltrials.gov/ct2/show/NCT01898884?term=vp20629&rank=1
http://www.thestreet.com/story/10901190/1/intellect-neurosciences-inc-obtains-ox1-phase-1b-draft-report-showing-the-companys-lead-alzheimers-candidate-was-safe-and-well-tolerated-at-all-dose-levels-tested.html
~Shire has Exclusive License Agreement for OX1
~Possible Orphan Drug candidate
~2011 agreement of milestone payments up to $120M to ILNS from Shire Plc with successful advancements of product to market plus tiered royalty based on annual net sales
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8168884
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10153122

My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.